| Date & Time | 20-23 September 2023 |
|---|---|
| Location | Milan, Italy |
The INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE (CICON)–TRANSLATING SCIENCE INTO SURVIVAL meeting series launched in 2015 under the patronage of the Cancer Research Institute (CRI), the American Association for Cancer Research (AACR), and the European Network for Cancer Immunotherapy.
Previous editions of the conference gathered on average 1200 cancer immunology and immunotherapy specialists from all over the world, granting the launch of most innovative diagnostic and therapeutic products. This year’s edition will take place between 20-23 September in Milano, Italy.
CICON23 will bring together top scientists and clinicians – such as the Nobel Laureate Jim Allison, Arlene Sharpe, PadmaneeSharma, OzlemTureci, Laurance Zitvogel, or Shannon Turley. The conference programming will include round tables on organ-specific malignancies (i.e. breast cancer, prostate cancer, etc.), and industry-focused lunches. Scientific lectures will aslo be streamed live and online discussions allowed.
CICON23 is the ideal forum to:
- Get updated on most recent advancements on basic, translational, clinical and reverse translational research
- Explore omics and artificial intelligence-guided landscaping of neoplasms immune contextures
- Discuss data on immunomodulator combinations and sequences in various neoplasm and therapeutic settings (metastatic, adjuvant and neoadjuvant)
- Discuss the mechanisms of resistance and the value of response and prognostic biomarkers
- Interact with experts and decision-makers, and enroll them in new product development or validation.
Learn more about the conference here.
